- Evolution of treatment patterns and survival outcomes in patients ...🔍
- Treatment Patterns and Outcomes in Patients With Metastatic ...🔍
- 1340P Real|world treatment patterns and outcomes in patients 🔍
- Real|world treatment patterns and survival outcomes for patients ...🔍
- Real|world treatment patterns and outcomes of patients with ...🔍
- Lung Cancer🔍
- 933 Real|world treatment patterns and clinical outcomes in patients ...🔍
- Real|World Treatment Patterns and Outcomes Among Patients With ...🔍
Treatment patterns and outcomes of patients with metastatic non ...
Evolution of treatment patterns and survival outcomes in patients ...
Changes in the SACT regimens due to toxicity or patient choice were not considered as a change in line of therapy. Overall survival (OS) was ...
Treatment Patterns and Outcomes in Patients With Metastatic ...
The median overall survival was longer in patients who received life-prolonging therapies (23.7 months; 95% confidence interval: 22.3-25.1 ...
1340P Real-world treatment patterns and outcomes in patients (pts ...
1340P Real-world treatment patterns and outcomes in patients (pts) with advanced, ALK+ non-small cell lung cancer (NSCLC) in Europe · Background. The ...
Real-world treatment patterns and survival outcomes for patients ...
Non-small cell lung cancer (NSCLC) accounts for most lung cancer cases (84%); it has a poor prognosis, with a 5-year overall survival (OS) of 34 ...
Real-world treatment patterns and outcomes of patients with ...
Request PDF | Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after ...
Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard ...
Real-world treatment patterns and outcomes of patients with ... - OUCI
Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in ...
933 Real-world treatment patterns and clinical outcomes in patients ...
This study aimed to further describe treatment patterns and clinical outcomes in metastatic non-squamous NSCLC patients receiving first-line pembrolizumab- ...
Real-World Treatment Patterns and Outcomes Among Patients With ...
Introduction: Programmed cell death protein-1 (PD-1)/ programmed death-ligand 1 (PD-L1) inhibitors are standard-of-care treatment for metastatic ...
(PDF) Treatment Patterns and Clinical Outcomes Among Patients ...
Among patients with metastatic non-small cell lung cancer without actionable genomic alterations previously treated with platinum + ICIs, non- ...
Patient Characteristics, Treatment Patterns, and Clinical Outcomes ...
Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients ... Metastatic (Stage IIIB–IV) Non-Small Cell Lung Cancer in a ...
Real-world treatment patterns and clinical outcomes in patients with ...
The percentage was calculated based on the total number of patients available within each level; unknown and missing data were not included.
Treatment patterns and outcomes in patients with metastatic gastric ...
In addition, there was no significant difference in OS between monotherapy and combination therapy as the third-line treatment for MGC (T-based monotherapy vs.
Treatment patterns and oncological outcomes of older adults with ...
... treatment outcomes in mHSPC patients also differ according to patient age of metastatic diagnosis. ... not receive life-prolonging systemic ...
Treatment Patterns for Patients With Advanced/Metastatic Cancers ...
There were no major differences in 1L, second-line, or third-line therapy by site of care. Patients with aNSCLC in physician office had longer ...
for patients with chemorefractory metastatic colorectal cancer (mCRC) with demonstrated ... Treatment patterns and outcomes of patients with ...
Treatment patterns and survival outcomes in patients with non ...
This article describes the comprehensive treatment patterns and survival outcomes for patients with non-metastatic early-onset PC (EOPC) from a ...
Treatment patterns and outcomes for patients with unresectable ...
12-month survival was ≥80.1%; proportions were highest forpatients treated with nivolumab + ipilimumab (86.6%). All treatments relatively well ...
Real-World Clinical Outcomes and Treatment Patterns Among Black ...
... patients with non-metastatic castration-resistant prostate cancer. ... Race and treatment outcomes in patients with metastatic castration ...
Treatment Patterns and Outcomes in Patients With Metastatic ...
We used a database of electronic medical records from over 2500 patients with metastatic castration-resistant prostate cancer to identify real- world treatment ...